Cargando…
Antiviral Activity of Oligonucleotides Targeting the SARS-CoV-2 Genomic RNA Stem-Loop Sequences within the 3′-End of the ORF1b
Increased evidence shows vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibited no long-term efficacy and limited worldwide availability, while existing antivirals and treatment options have only limited efficacy. In this study, the main objective was the development...
Autores principales: | Stincarelli, Maria Alfreda, Rocca, Arianna, Antonelli, Alberto, Rossolini, Gian Maria, Giannecchini, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696570/ https://www.ncbi.nlm.nih.gov/pubmed/36365037 http://dx.doi.org/10.3390/pathogens11111286 |
Ejemplares similares
-
Antiviral Activity
against SARS-CoV-2 of Conformationally
Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme
2
por: Quagliata, Michael, et al.
Publicado: (2023) -
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein
por: Stincarelli, Maria Alfreda, et al.
Publicado: (2023) -
Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19
por: Stincarelli, Maria Alfreda, et al.
Publicado: (2022) -
A Strategy Based on Loop Analysis to Develop Peptide Epitopes: Application to SARS-CoV-2 Spike Protein
por: Di Vona, Maria Luisa, et al.
Publicado: (2021) -
Oligonucleotide-Based Antiviral Strategies
por: Schubert, S., et al.
Publicado: (2006)